Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2013, Article ID 347520, 9 pages
http://dx.doi.org/10.1155/2013/347520
Review Article

Adverse Event Burden, Resource Use, and Costs Associated with Immunosuppressant Medications for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review

1GlaxoSmithKline, U.S. Health Outcomes, 5 Moore Drive, Research Triangle Park, NC 27709, USA
2United BioSource Corporation, 7101 Wisconsin Avenue Suite 600, Bethesda, MD 20814, USA
3Human Genome Sciences, Medical Affairs, 14200 Shady Grove Road, Rockville, MD 20850, USA
4Washington Hospital Center, Division of Rheumatology, 110 Irving Street NW, Washington, DC 20010, USA

Received 14 December 2012; Revised 17 February 2013; Accepted 25 February 2013

Academic Editor: Kenneth C. Kalunian

Copyright © 2013 A. Oglesby et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

A. Oglesby, A. J. Shaul, T. Pokora, et al., “Adverse Event Burden, Resource Use, and Costs Associated with Immunosuppressant Medications for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review,” International Journal of Rheumatology, vol. 2013, Article ID 347520, 9 pages, 2013. https://doi.org/10.1155/2013/347520.